Managed care considerations in the treatment of HER2-positive advanced breast cancer: A closer look at recent advances for improved patient outcomes Journal Article

  


Author: Modi, S.
Article Title: Managed care considerations in the treatment of HER2-positive advanced breast cancer: A closer look at recent advances for improved patient outcomes
Abstract: HER2 targeted therapies have revolutionized outcomes for patients with HER2+ breast cancer. Next generation ADCs with advanced pharmaceutical properties also offer the potential role to expand the target landscape and target thresholds beyond HER2+ breast cancer.
Keywords: overall survival; genes; neoplasm metastasis; drug combinations; trastuzumab; antineoplastic agents -- therapeutic use; education, continuing (credit); chemotherapy, cancer; breast neoplasms -- drug therapy; outcomes (health care); breast neoplasms -- familial and genetic; breast neoplasms -- prognosis; breast neoplasms -- mortality; epidermal growth factor receptors; drug development -- trends; neoplasm invasiveness -- drug therapy; survival rate -- trends
Journal Title: Journal of Managed Care Medicine
Volume: 27
Issue: 2
ISSN: 1094-1525
Publisher: National Association of Managed Care Physicians Medical Director's Institute  
Date Published: 2024-04-01
Start Page: 40
End Page: 43
Language: English
PROVIDER: EBSCOhost
PROVIDER: cinahl plus with full text
DOI/URL:

https://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,shib&db=rzh&AN=179530676&authtype=sso&custid=s2915669&site=ehost-live&scope=site&custid=s2915669
Notes: Accession Number: 179530676 -- Entry Date: 20240913 -- Revision Date: 20240913 -- Publication Type: Journal Article; CEU; tables/charts -- Journal Subset: Biomedical; Health Services Administration; Peer Reviewed; USA -- Special Interest: Oncologic Care -- NLM UID: 9807949. -- Source: CINAHL Plus with Full Text